Delisted from NYSE in Feb 2023
QNGY - Quanergy Systems, Inc.
NYSE
->
Technology
->
Scientific & Technical Instruments
Sunnyvale,
United States
Type: Equity
QNGY price evolution
QNGY
| (in millions $) | 30 Oct 2022 | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $0.82 | $0.98 | ||
| Inventory | $5.52 | $3.29 | ||
| Total current assets | $38.05 | $38.66 | ||
| Long term investments | ||||
| Property, plant & equipment | $1.99 | $2.16 | ||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $51.03 | $52.26 | ||
| Current liabilities | ||||
| Accounts payable | $4.47 | $4.2 | ||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $16.7 | $13.65 | ||
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $26.22 | $26.2 | ||
| Shareholders' equity | ||||
| Retained earnings | -$437.95 | -$412.28 | ||
| Other shareholder equity | -$0.08 | -$0.07 | ||
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2022 | 31 Jan 2021 | 31 Jan 2020 | |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.98 | $0.3 | ||
| Short term investments | ||||
| Net receivables | $0.65 | $0.72 | ||
| Inventory | $3.24 | $4.82 | ||
| Total current assets | $31.2 | $1 | $0.3 | |
| Long term investments | ||||
| Property, plant & equipment | $1.91 | $2.81 | ||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $36.65 | $278.84 | $0.39 | |
| Current liabilities | ||||
| Accounts payable | $2.38 | $1.55 | ||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $42.36 | $0.08 | $0.39 | |
| Long term debt | $32.82 | $39.4 | ||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $102 | $46.36 | $0.39 | |
| Shareholders' equity | ||||
| Retained earnings | -$307.6 | -$10.53 | -$0.02 | |
| Other shareholder equity | -$0.06 | -$0.06 | ||
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2022 | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1.19 | $1.37 | $3.93 | |
| Cost of revenue | ||||
| Gross Profit | -$1.26 | -$0.49 | -$0.01 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $16.75 | $61.81 | $40.95 | |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0 | $0 | $0.03 | |
| Interest expense | -$7.66 | -$42.38 | -$25.11 | |
| Net income | ||||
| Net income | -$25.67 | -$104.68 | -$63.54 | |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2022 | 31 Jan 2021 | 31 Jan 2020 | |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3.93 | |||
| Cost of revenue | ||||
| Gross Profit | -$0.01 | |||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $40.95 | $0.56 | $0.02 | |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.03 | |||
| Interest expense | -$25.11 | -$5.97 | ||
| Net income | ||||
| Net income | -$63.54 | -$10.51 | -$0.02 | |
| Income (for common shares) | ||||
| (in millions $) | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 | 30 Oct 2021 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$0.43 | -$0.2 | -$0.05 | |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $26.39 | $18.03 | $48.68 | |
| Effect of exchange rate | -$0.02 | -$0.01 | ||
| Change in cash and equivalents | -$7.39 | -$4.93 | $18.51 | -$0.92 |
| (in millions $) | 31 Jan 2022 | 31 Jan 2021 | 31 Jan 2020 | |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$0.05 | -$276 | ||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $48.68 | $277.22 | $0.3 | |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $18.51 | $0.68 | $0.3 | |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |